Composition and preparation method thereof

文档序号:1233327 发布日期:2020-09-11 浏览:8次 中文

阅读说明:本技术 一种组合物及其制备方法 (Composition and preparation method thereof ) 是由 许玉良 曾冬梅 王润久 许金勇 于 2020-06-22 设计创作,主要内容包括:本发明公开了一种组合物,按照重量比计,包括:半枝莲10-20份,金钱草20-30份,紫草10-20份,穿破石40-60份。本发明提供的组合物至少具有以下优势之一①成分简单,其主要成分半枝莲,金钱草,紫草和穿破石均为常见的药材,来源广泛,取材方便,价格低廉;②制备方法简便,无需熬制或蒸煮,也不需要特殊的仪器设备,使用者可在家自行配制,即配即用;③治疗效果显著,无任何不良副作用;④成本低,适合大规模的推广。(The invention discloses a composition, which comprises the following components in percentage by weight: 10-20 parts of barbed skullcap herb, 20-30 parts of desmodium, 10-20 parts of lithospermum and 40-60 parts of cudrania cochinchinensis. The composition provided by the invention has at least one of the following advantages that the composition is simple in components, the main components of the composition are common medicinal materials, such as barbat skullcap, desmodium, lithospermum and cudrania cochinchinensis, the source is wide, the material is convenient to obtain, and the price is low; the preparation method is simple and convenient, boiling or steaming is not needed, special instruments and equipment are not needed, and a user can prepare the medicine at home, and the medicine can be used after being prepared; the treatment effect is obvious, and no adverse side effect exists; fourthly, the cost is low, and the method is suitable for large-scale popularization.)

1. The composition is characterized by comprising the following components in parts by weight:

10-20 parts of barbed skullcap herb, 20-30 parts of desmodium, 10-20 parts of lithospermum and 40-60 parts of cudrania cochinchinensis.

2. The composition as claimed in claim 1, which comprises 13-19 parts by weight of barbed skullcap herb, 22-26 parts by weight of longhairy antenoron herb, 13-18 parts by weight of sinkiang arnebia root and 45-57 parts by weight of cudrania cochinchinensis.

3. The composition according to claim 1, comprising 16 parts of barbed skullcap herb, 25 parts of longhairy antenoron herb, 15 parts of sinkiang arnebia root and 52 parts of cudrania cochinchinensis.

4. The composition of claim 1, wherein the composition ingredients are mixed and milled to form a powder.

5. The composition of claim 1, wherein the composition comprises, by weight, 10-20 parts of barbed skullcap herb, 20-30 parts of longhairy antenoron herb, 10-20 parts of sinkiang arnebia root, and 40-60 parts of cudrania cochinchinensis.

6. The composition of claim 1, wherein the composition comprises 13-19 parts by weight of barbed skullcap herb, 22-26 parts by weight of longhairy antenoron herb, 13-18 parts by weight of sinkiang arnebia root and 45-57 parts by weight of cudrania cochinchinensis.

7. The composition of claim 1, wherein the composition comprises 16 parts by weight of sculellaria barbata, 25 parts by weight of lysimachia christinae hance, 15 parts by weight of lithospermum erythrorhizon and 52 parts by weight of radix cudraniae.

8. A process for the preparation of a composition according to any one of claims 1 to 7, characterized in that it comprises the following steps: mixing and grinding the components of the composition to form medicinal powder.

9. The method of claim 8, further comprising separately pulverizing the composition ingredients and sieving the pulverized composition ingredients through an 80 mesh sieve before mixing the composition ingredients.

10. Use of the composition of any one of claims 1-7, or the composition prepared according to claim 8 or 9, for the treatment of, or for the manufacture of a medicament for the treatment of, uterine fibroids.

Technical Field

The invention relates to the field of pharmaceutical preparations, in particular to a composition capable of treating hysteromyoma and application thereof.

Background

Uterine fibroids are the most common benign tumors in female reproductive organs, and are also one of the common tumors in the human body. Hysteromyoma is mainly formed by hyperplasia of uterine smooth muscle cells, and is commonly manifested by uterine bleeding, pain, abdominal mass, compression symptoms of adjacent organs, leukorrhagia, anemia, cardiac dysfunction and the like. Some patients have no symptoms, and the patients are usually found to have the hysteromyoma in gynecological general survey. It is commonly seen in 30-50 years old, and can be classified into intramural, subplasmic membrane, submucosal and intratough fibroid hysteromyoma according to the location of the myoma in the myoma wall. According to the traditional Chinese medicine, the hysteromyoma belongs to 'abdominal mass', the pathogenesis of the hysteromyoma is viscera dysfunction, visible pathogens such as blood stasis, phlegm stagnation, damp turbidity and the like are generated in succession, the uterus is accumulated, and the chronic disease is related to personal state and diet. During its development, the yin and blood are continuously consumed and the healthy qi is consumed. The patients mostly present with dull tongue, swollen tongue, tooth marks on the tongue edge, deep and thready pulse, and the symptoms of qi deficiency are usually accompanied by the symptoms of heavy abdomen, lassitude in loin and legs, dizziness and hypodynamia due to the excessive menstruation and the prolonged menstrual period. The primary symptoms of deficiency of the original qi are manifested as blood-borne lumps, sometimes with abdominal pain, and tongue with ecchymosis. In chronic diseases, qi deficiency involves yang deficiency, water-dampness is not transformed, and dampness is collected as phlegm, phlegm is sticky, and phlegm-blood stasis is combined.

At present, many traditional Chinese medicines are used for treating uterine fibroid, for example, the Chinese patent publication No. CN 102293991A discloses a secret recipe for treating uterine fibroid, which comprises 5-20% of dragon's blood, 5-20% of cattail pollen, 3-15% of amber, 5-20% of rhizoma alismatis, 5-20% of Chinese sage herb, 5-20% of cudrania cochinchinensis, 5-20% of oldenlandia diffusa, 5-20% of rhizoma sparganii, 5-20% of rhizoma zedoariae, 5-20% of leech, 5-20% of spora lygodii, 5-20% of pseudo-ginseng, 5-20% of red peony root, 5-20% of spina gleditsiae, 5-20% of lychee seed, 5-20% of chicken's gizzard-membrane, 5-20% of garden balsam; also disclosed in Chinese patent publication No. CN 103285172A is a Chinese medicinal composition for treating hysteromyoma and endometrial cancer, which comprises 13-30 parts of lithospermum, 15-30 parts of oldenlandia diffusa, 10-20 parts of selfheal, 10-20 parts of eclipta, 15-30 parts of gypsum rubrum and 10-20 parts of sculellaria barbata. However, the traditional Chinese medicine for treating hysteromyoma has more traditional Chinese medicines, is inconvenient to prepare and has higher cost, so that a traditional Chinese medicine composition for treating hysteromyoma, which has fewer medicines, is convenient to prepare and apply and has a remarkable treatment effect, is urgently needed.

Disclosure of Invention

Based on the above, the invention aims to provide the traditional Chinese medicine composition which is simple in preparation method, can be prepared by a patient at home, can be used at any time, and has an obvious curative effect.

The purpose of the invention is realized by the following technical scheme:

the invention provides a composition, which comprises the following components in percentage by weight: 10-20 parts of barbed skullcap herb, 20-30 parts of desmodium, 10-20 parts of lithospermum and 40-60 parts of cudrania cochinchinensis.

Wherein the content of the first and second substances,

scutellaria barbata (school name: Scutellaria barbata D.Don) (plant material of Jiangsu province), which is called as follows: stringy exterior syndrome (Sichuan Chengdu), thin baikal skullcap root (Sichuan Puge), tooth-brush grass (Jiangsu Suzhou), Tianji grass (Jiangsu Yixing), Shuichu baikal skullcap root (Jiangsu Nanjing), and Han Xin grass (Guangzhou plant). The herba Scutellariae Barbatae has effects in clearing away heat and toxic materials, promoting blood circulation, dispelling blood stasis, relieving swelling and pain, and resisting cancer. Is cold in nature and sour in taste, and the whole herb contains various vitamins, trace elements, amino acids and other components. Has the effects of cooling blood, removing toxic substances, removing blood stasis, relieving pain, relieving swelling, clearing heat and promoting diuresis.

The herba Lysimachiae Christinae is fresh or dried whole plant of Lysimachia Hance of Primulaceae, Lysimachia christinae Hance, also named herba Desmodii Styracifolii, herba Lobeliae chinensis, herba Ardisiae Japonicae, and radix rehmanniae. Lysimachia christinae Hance is bitter, sour and slightly cold in taste. It enters liver, gallbladder, kidney and bladder meridians. Has the functions of clearing away heat and toxic material, promoting urination, removing urinary calculus, promoting blood circulation and dissipating blood stasis. Can be used for treating liver and gall calculus, cholecystitis, icterohepatitis, urinary calculus, edema, traumatic injury, venomous snake bite, and muscarine and drug poisoning; it is used externally to treat suppurative inflammation, burn and scald.

Lithospermum erythrorhizon Sieb. et Zucc. is a plant of the genus Lithospermum in the family Boraginaceae. The dried root is used as a medicine, has the effects of cooling blood, activating blood circulation, clearing heat, detoxicating and promoting eruption, and is used for treating diseases such as warm heat macula, damp-heat jaundice, hematemesis, maggot blood, hematuria, stranguria with turbid urine, bloody dysentery, heat accumulation constipation, burn, eczema, erysipelas and the like.

Breaking the stone: \ 33896, Zhi and jin Chan (synonyms) Cudrania tricuspidata root (Qian jin Fang), Chuan broken stone (preparation of herb) and Gossypium hirsutum root, shell removing, Huanglong shell removing, morning glory introducing stone, Jinwaistband, yellow snake root, mountain lichee and Qian Piao (source) Kudo et Masam, and root introducing medicine. [ PROPERTIES, WESTERN AND CHANNEL FENCH ] is slightly bitter and neutral. [ FUNCTIONS ] can relieve cough, resolve phlegm, dispel wind, promote diuresis, remove blood stasis, and relieve pain. Can be used for treating pulmonary tuberculosis, icterohepatitis, hepatosplenomegaly, gastric ulcer, duodenal ulcer, rheumatic lumbago, and skelalgia; it is used externally to treat fracture and traumatic injury.

In the application, the radix cudraniae is used as a monarch drug, the channels are penetrated, the stasis is broken, the sculellaria barbata is used as a ministerial drug, the radix cudraniae is used for assisting the radix cudraniae to detoxify and remove stasis, and improving and inhibiting tumors, and the lithospermum and the longhairy antenoron herb are used as guides for clearing heat and cooling blood, promoting diuresis, removing stasis, resisting bacteria and diminishing. The combination of the arnebia root and the desmodium helps the monarch drugs to remove blood stasis and eliminate mass, soften hardness and dissipate stagnation. The applicant combines the cudrania cochinchinensis, the sculellaria barbata, the lithospermum and the longhairy antenoron herb with each other, is used for inhibiting or treating the uterine fibroid, and has obvious effect and no toxic or side effect.

In one embodiment of the application, the composition comprises 13-19 parts of barbed skullcap herb, 22-26 parts of desmodium, 13-18 parts of lithospermum and 45-57 parts of cudrania cochinchinensis by weight ratio.

In one embodiment of the present application, the medicine comprises 16 parts of barbed skullcap herb, 25 parts of longhairy antenoron herb, 15 parts of sinkiang arnebia root and 52 parts of cudrania root by weight.

In one embodiment of the present application, the composition ingredients are mixed and ground to form a powder.

In one embodiment of the application, the composition comprises, by weight, 10-20 parts of barbed skullcap herb, 20-30 parts of longhairy antenoron herb, 10-20 parts of sinkiang arnebia root and 40-60 parts of cudrania cochinchinensis.

In one embodiment of the application, the composition comprises 13-19 parts of barbed skullcap herb, 22-26 parts of desmodium, 13-18 parts of lithospermum and 45-57 parts of cudrania cochinchinensis by weight ratio.

In one embodiment of the present application, the composition consists of 16 parts by weight of barbed skullcap herb, 25 parts by weight of longhairy antenoron herb, 15 parts by weight of sinkiang arnebia root and 52 parts by weight of cudrania cochinchinensis.

In another aspect, the present application provides a method for preparing the above composition, which comprises the following steps: mixing and grinding the components of the composition to form medicinal powder.

In one embodiment of the present application, the preparation method further comprises pulverizing the composition ingredients, sieving with an 80-mesh sieve, and mixing and grinding.

In one embodiment of the present application, the composition is mixed and ground to form a powder, which is taken directly with warm boiled water half an hour before meals twice a day.

In another aspect, the present application provides the use of the above composition, or the above prepared composition, for inhibiting and/or treating uterine fibroids.

In a further aspect, the present application provides the use of a composition as described above, or a composition prepared as described above, in the preparation of a medicament for inhibiting and/or inhibiting

Application in the medicine for treating hysteromyoma.

The invention has at least one of the following advantages:

the invention provides a composition, which has simple components, and the main components of the composition are common medicinal materials, namely sculellaria barbata, desmodium, lithospermum and cudrania cochinchinensis, and the composition has wide sources, convenient material acquisition and low price; the preparation method is simple and convenient, boiling or steaming is not needed, special instruments and equipment are not needed, and a user can prepare the medicine at home, and the medicine can be used after being prepared; the treatment effect is obvious, and no adverse side effect exists; fourthly, the cost is low, and the method is suitable for large-scale popularization.

Detailed Description

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

6页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:春桑叶水提取物在制备治疗亨廷顿病药物中的应用

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!